Sign In
Buy SCD
$15.48
+0.0200 (+0.129%)
At Close: Jul 31, 2026
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to
SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a
LMP Capital and Income Fund Inc. Authorizes 1-For-3 Rights Offering
08:00am, Monday, 02'nd Jun 2025
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
SCD: This Hybrid Tech/Energy CEF Raised The Distribution, Now Has A Big Discount
11:08am, Monday, 21'st Apr 2025
Heightened market volatility presents unique buying opportunities for income investors, particularly in the technology and energy sectors, which show signs of bottoming as Q1 earnings season approache
LMP Capital and Income Fund Inc. Announces Results of Annual Meeting of Stockholders
08:00am, Thursday, 17'th Apr 2025
NEW YORK--(BUSINESS WIRE)--Category: Fund Announcement.
Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor
08:30am, Tuesday, 15'th Apr 2025
Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological effects of the drug. The pharmacodyn
– AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development – Aramchol Meglumine, a
DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
3 Schwab ETFs to Buy With the VIX On the Rise
02:40pm, Wednesday, 12'th Mar 2025
At the time I'm writing this, the volatility index (VIX) closely watched by many investors is trading above 25, a key level many in the market attribute to heightened investor uncertainty.
SCD: Continuing To Perform Well As Discount Narrows Further
06:28pm, Wednesday, 26'th Feb 2025
LMP Capital and Income Fund (SCD) offers a fairly diversified portfolio but is more uniquely positioned, with its largest allocations being to MLPs and technology sectors. The fund's discount has narr
5 Best CEFs This Month For Nearly 10% Yield (January 2025)
08:00am, Saturday, 25'th Jan 2025
For income investors, closed-end funds, or CEFs, remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. CEFs are generall
SCD: Monthly Paying CEF With Energy And Tech Exposure
03:05pm, Tuesday, 07'th Jan 2025
LMP Capital and Income Fund offers an 8% dividend yield, focusing on income through diverse investments in MLPs, REITs, and common stocks. SCD's strategy includes a mix of energy and tech stocks, prov
-- Collaboration to leverage Orna's differentiated lipid nanoparticle (LNP) delivery solutions for patients with SCD and TDT -- -- Orna to receive an upfront payment and is eligible to receive potenti
LMP Capital and Income Fund Inc. (SCD or “the Fund”; CUSIP: 50208A102) Announces Notification of Sources of Distributions
08:00am, Tuesday, 31'st Dec 2024
NEW YORK--(BUSINESS WIRE)--Category: Distribution Related.
5 Best CEFs This Month For 9% Yield (December 2024)
08:30am, Sunday, 29'th Dec 2024
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs,
